. The value of routine post-operative irradiation in patients with small breast tumours and without axillary lymph-node metastases is uncertain, and in more advanced operable cases there is doubt about whether the irradiation is best given before or after surgical treatment. McKinnon (1951a; 1954) and also Park and Lees (1951) go so far as to doubt whether the methods of treatment employed for breast cancer at the present time have any value at all in prolonging life-the prognosis, they claim, being determined by the type of tumour and not by the treatment. Even more difficult to assess in terms of survival is the role of palliative radiotherapy, hormone administration, and endocrine surgery in advanced cases, and the place of prophylactic castration in early as well as late cases.
The factor largely responsible for the difficulties in trying to assess the value of treatment in breast cancer is the wide variation in the natural history of the disease itself (Bloom, 1950a; Bloom and Richar'dson, 1957) .
Attention has already been drawn to the broad spectrum of malignancy which exists in all groups of cases of breast cancer which are classified according to a clinical staging system. A more homogeneous grouping of cases is possible by taking into account the histological type *Past Pathologists, Bland-Sutton Institute, Middlesex Hospital, London. of the tumour (grade) in addition to its clinical extent (stage) (Bloom, 1950a (Bloom, , 1956 (Bloom, , 1958 . Such a classification may lead to a more accurate assessment of the different lines of treatment for this disease. However, it is only from a knowledge of the natural history of untreated cases that a background will be provided against which the merits of treatment itself can be judged.
Although many papers have been written on various aspects of breast cancer there have been few reports on the untreated disease. With the advent of radiotherapy and the discovery of the effects of various hormonal agents, adrenalectomy, and hypophysectomy upon the course of the disease, it is rare to-day for a patient with carcinoma of the breast to remain untreated. For information on the natural history of the untreated disease one must turn to case records from the past, to the publications of 20 to 30 years ago.
Greenwood (1926) published a detailed analysis of 4,238 patients with untreated cancer at seven different primary sitzs, seen in five centres in Great Britain. There were 651 cases of breast cancer, for which the average duration of life from onset of symptoms was 3.2 years; the median duration (when 50% of the patients were dead) was 2.3 years.
Daland (1927) , in Boston, studied 100 patients with untreated cancer of the breast, of whom 11 came to necropsy. The average survival was 3.3 years and the median survival 2.5 years. Nathanson and Welch (1936) also investigated the duration of life in 100 untreated cases which included 50 of Daland's original series with results comparable to this. Forber (1931) , in a study of incurable cancer among patients seen in East London during 1928 and 1929, reported the mean duration of life from onset of symptoms in a series of 64 breast cases as 39.3 months (omitting two cases of alleged duration of 40-41 years). Forber also quoted some unpublished data of the Ministry of Health concerning 466 untreated breastcancer patients collected from nine English cities in whom the mean natural duration of life was 50.7 months: when 45 cases with histories extending over ten years were excluded the mean duration was reduced to 31 months. Wade (1946) collected 27 untreated patients at the National Radium Centre, General Infirmary, Leeds, between 1931 and 1941 and compared their survival with that of a group of 177 treated advanced cases from the same centre. She also reviewed the literature on untreated breast cancer up to the time of her report (777 cases in all) and found that the mean duration of life from the onset of symptoms for the whole series was 38.5 months, and for 26 of her own cases 32.6 months.
The purpose of this paper is to present a series of 250 cases of untreated breast cancer from the early clinical and post-mortem records of the Middlesex Hospital; to correlate the histological grade with survival in 86 cases in which sections of post-mortem material were available; and to compare the pattern of survival of these patients with a series of treated cases which we have previously studied at the same hospital (Bloom and Richardson, 1957 Governors of the Middlesex Hospital that a friend of his, who wished to remain anonymous, desired to contribute a sum of money for the establishment of a cancer charity for the hospital. The principal objects of the bequest were ". the relief of persons afflicted with cancer, and the investigation of a complaint which, though extremely common, is, both with regard to its natural history and cure, but imperfectly known."t Howard's generous friend was later known to be Samuel Whitbread (1720-1796).
In June, 1792, a ward containing 12 beds was ready to receive cancer cases at the Middlesex Hospital. These included not only patients for whom there was a reasonable prospect of relief by opzration or otherwise but also those whose disease was hopelessly advanced and who would be offered an asylum for life. The regulations stated that these patients "shall remain an unlimited time, until either relieved by art or released by death, unless it should be thought necessary to discharge them for ill-behaviour" (Wilson, 1845 (Coupland, 1902 JULY 28, 1962 Lazarus-Barlow and Leeming (1924) , with a view to providing a series of controls for cancer treatment, presented the natural duration of cancer for a number of primary sites based on the mean survival of untreated cases seen at the Middlesex Hospital between 1883 and 1922. There were 243 cases of breast cancer in this series, and these have also been included in papers published by Greenwood (1926) and by Wade (1946 Only 7% of the patients came to hospital within six months of the initial symptom and 29% within the first year (Table III) . Nearly three-quarters (71 %) of the cases delayed for over 12 months: in 24% more than three years elapsed and in 12% more than five years. The longest delay was 16 years.
Over the past 50 years the delay in seeking medical advice in patients with cancer of the breast has gradually become shorter (Lewis and Rienhoff, 1932; Eggers et al., 1941 ; Harrington, 1952; Robbins et al., 1959) . In a series of treated cases also from the Middlesex Hospital seen between 1936 and 1942, 65% presented within six months and 85% within one year of the first symptom (Bloom, 1950b) . The extent of the disease was staged by the Manchester system (Paterson, 1948) and was carried out in retrospect from the clinical notes (Table IV) . The high proportion of patients with advanced disease is to be expected in an untreated group the majority of whom presented for terminal care. (Greenwood, 1926; Daland, 1927; Nathanson and Welch, 1936; Forber, 1931 ; Wade, 1946) (Tables  VI and VII; Fig. 2) .
The "natural" survival rate of a group of women of similar age distribution to the present series has been estimated from specially computed life tables (see Appendix) and is plotted for comparison with that of the untreated patients (Fig. 1) .
The duration of the disease in patients with untreated cancer of the breast is based on the length of symptoms and the interval between the first attendance at hospital and death. The duration of symptoms, which usually constitutes a major part of the survival period in such cases, has to be determined from statements made by the patient or her relatives, and can therefore at best serve only as a rough yardstick. Furthermore, the accuracy of the history will be influenced by the care with which it is taken. From the detailed nature of the clinical notes and the obvious interest in malignant survive for five or even ten or more years without any specific treatment. All published series on this subject contain instances of prolonged survival, and this must be taken into account when considering the possible benefits derived from definitive treatment.
Five per cent. of Daland's patients and approxiiately 4% of the present series were still alive at 10 years (Table VII) . Daland (1927) cites a patient, not included in his series, who had a breast tumour for 35 years and who was still alive at the age of 80. She had been examined by Greenough in 1914 and thought to be inoperable because, even at that time, her whole breast was destroyed by growth.
Wade (1946) had one patient who lived for 22 years, and another for 13 years. Haagensen (1956) gives the history of one of his patients who was alive with breast cancer 27 years after discovering a lump in her breast and 10 years after a positive biopsy.
The longest survivor in the present series (Case C.R. 71) lived for 18 years and 3 months after the discovery of a lump of approximately half-inch (1.3 cm.) diameter in the left breast at the age of 46. She did not seek advice for 16 years, by which time the whole breast was replaced by a fungating tumour with satellite nodules in the surrounding skin. Ulceration had been present for 12 years. She finally died two years and three months after admission, and necropsy showed metastases in axillary nodes, lungs, pleura, and ribs.
One of our cases (Case C.R. 48) lived for 15 years and 7 months with a slowly growing lump in the breast which finally ulcerated. Seven months after admission to hospital she died with multiple visceral metastases: the immediate cause of death was haemorrhage from a gastric ulcer. A further patient (Case C.R. 33) survived 15 years. having been aware of a lump in the breast for 14 years, and died from pleural and hepatic metastases. The fourth long survivor (Case C.R. 741) died after 13 years and 10 months. There had been a slowly growing lump in the left breast before admission, at which time she had an ulcerated mass 5 cm. in diameter with enlarged nodes in both axillae and oedema of the arm: she died with pleural and liver secondaries and a deposit in the left kidney. Five further patients lived 10 years or more.
Spontaneous Regression
Examples of spontaneous regression of cancer have been recorded from time to time, but many of these are based on inadequate evidence. Everson and Cole (1956) , who reviewed the literature, were able to find only 47 such cases with biopsy confirmation by a competent pathologist and no significant therapy. In none of the present series of untreated cases of breast cancer was spontaneous regression reported. In one case, however, the rate of growth of the primary tumour appeared to fluctuate considerably over several years. (Bloom and Richardson, 1957) . All the histological slides were examined without knowledge of the patients' history and only when grading had been completed were the notes studied for clinical details. a group of women with the same age composition as that of the untreated cases (see Appendix) has also been plotted in Fig. 3 (Bloom, 1950b) . A greater proportion of highly malignant grade III tumours was not found in the younger age-groups, there being a remarkably even distribution of tumours of low-and of high-grade malignancy throughout the various decades. Shimkin shown no significant or constant increase or decrease in mean life-span according to the age of onset in 623 untreated cases of breast cancer.
In the present series no significant relationship was found between age at onset of symptoms and outcome (Table IX) . A slight reduction in the three-year survival rate was noted in the 50-59 age-group, and this is in keeping with the findings of Richards (1948) and also of Smithers et al. (1952 ) , who report a particularly unfavourable prognosis for women in the fifties. This trend, however, was not evident in our five-year results.
Comparison of Untreated and Treated Cases
In a previous paper (Bloom and Richardson, 1957) This, however, has the obvious weakness of any factor based upon the patient's own observations, especially when the history so often extends over ma.ny months or even years. A further consideration is that the data in our untreated cases have been obtained from records dating back to over 150 years, to the time the first case was seen in 1805. Many deaths in this series could no doubt have been postponed for a time if certain nonspecific modern therapeutic agents, such as antibiotics and blood transfusion, had been available.
Nevertheless, the average duration of life and the 5-and 10-year survival rates found in the present series of untreated cases agree so closely with those obtained by other authors who have studied the untreated disease that we have been encouraged to proceed with the comparison of treated and untreated patients. It must be pointed out that the treated series is composed of cases which have to some extent been selected in that only those with histological material for grading could be included.
Although 84% of the patients were treated by a radical or modified radical operation (with or without ancillary irradiation) the criteria for operability during the earlier years of the period under review were not so strict as they are to-day and many advanced cases were subjected to surgery. Thus 27% of the cases followed for five years were classified as stage 3 or 4. The corresponding figures for those observed for 10 years and 15 years were 30% and 36% respectively.
Of the untreated series, 18% survived five years compared with 55% of those who were treated. At 10 years only 3.6% of the untreated patients were alive compared with 34% of the treated. The corresponding figure at 15 years was 0.8% compared with 22% (Table  XII) . Greater accuracy in prognosis of breast cancer can be obtained by considering the histological grade of malignancy of the primary tumour (Bloom, 1950a; Bloom and Richardson, 1957) . Eighty-six untreated and 1,246 treated cases have been compared in this way (Table X) . A striking difference is seen between the two series. Thus no patient with an untreated highly malignant grade III tumour survived five years, in contrast to 33% of those treated with this type of tumour. More than 80% of treated patients with tumours of low malignancy (grade I) survived for this period, compared with only 22% of the untreated group. The difference between the two series becomes even greater at 10 and 15 years. The mean survival of treated patients with grade I tumours dying within 15 years of the onset of symptoms was 90.1 months, compared with 47.3 months for those who were untreated. At the other end of the scale of malignancy, the average survival was 40.2 months for treated and 22 months for untreated grade III cases. Thus even in those patients destined to die from their disease treatment appears to prolong life appreciably. Burdick (1961) , in a series of 146 advanced cases of breast cancer, has reported on the results of palliative treatment which has included local surgery, irradiation, hormone therapy, and endocrine ablation (mainly bilateral oophorectomy).
This author calculated survival from onset of symptoms to death and obtained 5-and 10-year survival rates of 38% and 12% respectively. McKinnon (1951a; 1954) , who holds the opinion that early treatment of breast cancer fails to influence the mortality, thinks there is no evidence that treatment of the primary tumour materially prolongs life in the majority of those cases in which it does not cure the disease. He believes that treatment can only prevent death in "non-progressive," "non-lethal " forms of cancer and that high survival rates reported for breast cancer are due to the inclusion of such lesions which are thought to make up the majority of stage 1 cases. McKinnon (1955) (Bloom, 1958 We also hold the view that prognosis in breast cancer is largely determined by the type of tumour (Bloom, 1950a (Bloom, , 1950b Bloom and Richardson, 1957) (Fig. 4) , there is a marked difference between the treated and untreated series.
In the absence of primary treatment patients often linger for many months or years with large, foul ulcerating breast tumours which penetrate deep into the chest wall and produce much pain, discharge, and intermittent haemorrhage. To this picture may be added ulceration of axillary-node masses and of skin nodules, cancer-en-cuirasse, and gross oedema of the upper limb. In 68% of our untreated patients an ulcerating mass was present on admission to hospital. On No definite relationship was found between age and prognosis, although it is possible that the outlook for patients in the fifties may be slightly worse than for those in other age-groups.
Patients with breast cancer may survive for many years without specific treatment. Spontaneous regression was not observed in any cases in this series, although fluctuation in growth rate of the primary tumour was noted in one patient.
All patients were followed to death: 95% succumbed with distant metastases or/and extensive local cancer and in only 5 % death appeared to be the result of intercurrent disease. Frequently patients suffered for many months with extensive destructive lesions of the breast and chest wall.
The mean duration of life from onset of symptoms was 3 years: 18% survived 5 years, 3.6% 10 years, and 0.8% 15 years. The longest survival was 18 years and 3 months. Three other patients survived over 13 years.
Histological grade of malignancy was correlated with prognosis in 86 untreated cases in which the microscopical sections were available for study. The average survival from onset of symptoms for tumours of low malignancy (grade I) was 47.3 months and the 5-and 10-year survival rates 22% and 9% respectively. For tumours of intermediate malignancy (grade II) the average survival was 39.2 months and the 5-and 10-year survival rates 22% and 3%. The average survival for highly malignant (grade III) tumours was 22 months; there were no survivors at five years.
It is only against the background of untreated cases in the past that the merits of treatment in breast cancer to-day can be judged more fully. The untreated cases were seen over a period of 128 years ; in most the disease was very advanced at the first attendance and the greater part of its duration had to be based largely on the patient's own observations. In spite of these inherent difficulties an attempt has been made to compare the prognosis of untreated cases with a series of treated patients seen at the same hospital between 1936 and 1949 Trial, 1955) . We concluded that most cases of rheumatic fever responded to bed rest alone and that, though salicylates bring about symptomatic relief, they do not significantly alter the course of the disease or have any effect on cardiac status. Steroids had no demonstrable beneficial effect on the heart in most cases except possibly in the disappearance of soft diastolic murmurs, and this was shown in a later paper to have little effect on the findings five years later (Thomas, 1961) . They were, however, indicated in cases with cardiac enlargement and activity, for by suppressing the rheumatic activity they diminished the risk of failure. Also, they were useful in patients with established failure and activity; for after the activity had been controlled the failure responded to drugs such as digitalis and mersalyl. The conclusion of the analysis of all cases treated in the Co-operative Trial at the end of one and five years was that cortisone and A.C.T.H. had no advantage over salicylate, and we found little difference in end-results between our cases treated by bed rest and those treated in this trial.
A criticism of the treatment in the Co-operative Trial has been that the six-week courses were too short, and that had longer ones been used steroid might have been proved more effective than salicylates. With 
